🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Live from our Cancer Research Institute Seminar Series: Eli Van Allen Dana-Farber shares his pioneering work in clinical computational oncology, highlighting the molecular ‘logic’ of cancer in areas like integrative genomics and tumor immune biology. #CancerResearch

"Vera was diagnosed with bilateral #breastcancer at 39 years old. With guidance from BIDMC medical oncologist Gerburg Wulf, MD, she integrated western medicine with her natural healing, starting a new immunotherapy drug and brain radiation." ➡️bit.ly/3DgPIYR #BCSM

ICYMI: Maxwell Lloyd BIDMC Hematology/Oncology Fellowship on OncLive.com #SABCS24 discusses a real-world study of elacestrant outcomes based on prior treatment history and ESR1 mutation status in HR+/HER2-negative #BreastCancer ▶️bit.ly/4gitIvb #CancerResearch

We❤️our #CardioOnc team at #BIDMC! Their work on cardiotoxicity is incredibly important for improving long-term care practices for our patients with #cancer.

Shoutout to our colleagues Brian Carney, MD #Hematology and Richard Haspel, MD BIDMC Pathology for shedding light on the inequities patients with the sickle cell trait experience in the military, athletics, medicine, and more, and recommendations for change #MedTwitter

David McDermott, MD, Chief, #MedOnc BIDMC Department of Medicine on the KEYNOTE-564 trial - With the APD1 inhibitor improving not just disease-free survival but overall survival in the adjuvant setting, the key question now becomes: how do we use it, and for which patients? #KidneyCancer

Hispanic #BreastCancer patients are 2.47x more likely to experience treatment delays of 3+ months compared to non-Hispanic white (NHW) patients. However Hispanics with delayed treatment paradoxically exhibit better survival outcomes than NHWs with similar delays. #HealthEquity

🌟An outstanding year in review! We're grateful for our transplant and hepatobiliary surgical team for their dedication to innovative surgical techniques and outstanding patient care. Excited for what's in store in 2025!

For Surgical Grand Rounds on Wednesday, 1/8, we will be joined by Benjamin C. James, MD, MS, FACS (Benjamin James) on Financial Burden of Cancer. To virtually join, email [email protected] for more details. #BIDMC #Grandround

Congratulating Mark Callery, MD on his recent retirement from clinical practice. Grateful for his contributions to the Department of Surgery at BIDMC. #BIDMC #BILH #retirement #surgery

🔬#CancerResearch Spotlight: Taru Muranen 🇺🇦 Jenny Hogstrom created protocol to isolate patient derived organoids & cancer-associated fibroblasts, studying the tumor microenvironment's role in HR+ #BreastCancer cell growth & drug resistance⏩bit.ly/4auQxK6 📝Bio-protocol

Join us tomorrow, 1/23 at 4 PM for our Cancer Research Institute Seminar Series, featuring Brad Bernstein, Chair of Cancer Biology, Dana-Farber. His research specializes in chromatin mechanisms and the role of epigenetic gene regulation in diseases like cancer. #CancerResearch

Register now for the 5th Annual Liver Tumor Multidisciplinary Symposium on Feb 13, 2025! Information in the original post.

Register now for the 10th Annual RNA Symposium hosted by the HIRM and Dr. Frank Slack! Registration and information can be found in the original post.

Join us tomorrow, 2/6 at 4PM for our Cancer Research Institute Seminar Series, featuring Neil Vasan from Herbert Irving Comprehensive Cancer Center. The Vasan Lab uses functional genomics to understand how oncoproteins regulate breast cancer cell signaling, growth, & therapeutic response. #CancerResearch

📢 Live from our Cancer Research Institute Seminar Series! We’re thrilled to welcome physician-scientist Neil Vasan from @ColumbiaCancer as he presents Kinase Activation and Inhibition in Breast Cancer. Thank you for joining us! 🔬 #BreastCancerResearch #CancerScience

For Surgical Grand Rounds on Wednesday, 3/12, we will be joined by Charles Parsons, M.D on Robotic Acute Care Surgery at BIDMC. To virtually join, email [email protected] for more details. #BIDMC #Grandround

Tune in on Tues. March 11 at 3 PM EST to hear Dr. Alberto R. Kornblihtt, PhD present at the HiRM Seminar Series! “Control of alternative mRNA splicing by chromatin and transcription and the cure of an hereditary disease” To register click this link: qrco.de/bfm0at

BIDMC Cancer Research Institute is thrilled to welcome Michael J. Lee, led by Michael Lee from Systems Pharmacology at UMass Chan Medical School. Their groundbreaking work on drug therapy principles and mechanisms behind therapeutic activities is set to inspire and innovate!

Please join us on June 24 at 5 PM via Zoom for this free webinar lecture focusing on "Living with Lymphedema" will be presented by Kathleen Shillue, PT, DPT, OCS, CLT To register please click this link: redcap-edc.bidmc.harvard.edu/edata/surveys/…